The genetic landscape of HCC is well described, with mutations in the catenin beta 1 (CTNNB1), tumour protein p53 (TP53), and telomerase reverse transcriptase (TERT) being the most commonly observed driver mutations in HCC10–12. This evidence concerns the gene TERT and hepatocellular carcinoma.